Skip to main content
Year archive

China NT Pharma Group Company Limited — 2018 filings

All 46 regulatory filings released by China NT Pharma Group Company Limited (1011) in 2018, sourced directly from the official regulator.

46 Filings
2018 Period
2018 filings (46)
Filing Released Lang
VOLUNTARY ANNOUNCEMENT ON THE SUBMISSION OF NEW DRUG APPLICATION FOR PF708 TO THE US FDA AND THE EXPECTED APPROVAL IN 2019
Regulatory Filings
2018-12-11 English
Monthly Return of Equity Issuer on Movements in Securities For the month ended 30 November 2018
Regulatory Filings
2018-12-04 English
VOLUNTARY ANNOUNCEMENT - COMPLETION OF CLINICAL WORK ON THE CONSISTENCY EVALUATION FOR QUETIAPINE FUMARATE TABLET (SHUSI)
Regulatory Filings
2018-11-07 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2018
Capital/Financing Update
2018-11-02 English
VOLUNTARY ANNOUNCEMENT
Capital/Financing Update
2018-10-03 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2018
Share Issue/Capital Change
2018-10-03 English
Interim Report 2018
Interim / Quarterly Report H1 2018
2018-09-20 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2018
Share Issue/Capital Change
2018-09-06 English
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2018
Interim / Quarterly Report H1 2018
2018-08-21 English
VOLUNTARY ANNOUNCEMENT MILESTONE RESULT ACHIEVED IN THE PHASE II CLINICAL RESEARCH OF XI DI KE LOW-TO-MEDIUM RISK MYELODYSPLASTIC SYNDROME (MDS) TREATMENT
Regulatory Filings
2018-08-21 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2018
Capital/Financing Update
2018-08-02 English
NOTICE OF BOARD MEETING
Regulatory Filings
2018-07-30 English
VOLUNTARY ANNOUNCEMENT SUCCESSFUL ADMISSION OF XI DI KE INTO HUNAN PROVINCE'S MEDICINE CATALOGUE FOR MEDICAL INSURANCE
Regulatory Filings
2018-07-23 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2018
Regulatory Filings
2018-07-06 English
CLARIFICATION ANNOUNCEMENT - RESIGNATION OF INDEPENDENT NON-EXECUTIVE DIRECTOR CHANGE OF COMPANY SECRETARY, AUTHORISED REPRESENTATIVE AND AGENT FOR THE ACCEPTANCE OF SERVICE OF PROCESS AND NOTICE
Board/Management Information
2018-06-22 English
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION
Board/Management Information
2018-06-15 English
APPOINTMENT AND RESIGNATION OF INDEPENDENT NON-EXECUTIVE DIRECTOR AND CHANGE OF MEMBER OF BOARD COMMITTEES
Board/Management Information
2018-06-15 English
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 8 JUNE 2018
Declaration of Voting Results & Voting Rights Announcements
2018-06-08 English
Next Day Disclosure Return
Transaction in Own Shares
2018-06-04 English
VOLUNTARY ANNOUNCEMENT SMOOTH PROGRESS ACHIEVED IN THE CONSISTENCY EVALUATION FOR QUETIAPINE FUMARATE TABLET HUMAN BIOEQUIVALENCE RESEARCH AND CLINICAL TRIAL PROJECT
Regulatory Filings
2018-06-04 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2018
Regulatory Filings
2018-06-01 English
Next Day Disclosure Return
Transaction in Own Shares
2018-05-29 English
VOLUNTARY ANNOUNCEMENT SIGNIFICANT PROGRESS ACHIEVED FOR QUETIAPINE FUMARATE (SHUSI) EXTENDED-RELEASE PREPARATIONS PROJECT
Regulatory Filings
2018-05-29 English
VOLUNTARY ANNOUNCEMENT SUCCESSFUL ADMISSION OF XI DI KE INTO ANHUI PROVINCE'S MEDICINE CATALOGUE FOR MEDICAL INSURANCE
Regulatory Filings
2018-05-17 English
VOLUNTARY ANNOUNCEMENT ON POSITIVE STUDY RESULTS IN OSTEOPOROSIS PATIENTS FOR PF708 AND THE EXPECTED SUBMISSION OF NEW DRUG APPLICATION IN THE UNITED STATES IN THE THIRD QUARTER OF 2018
Regulatory Filings
2018-05-16 English
CLARIFICATION ANNOUNCEMENT IN RELATION TO ANNUAL REPORT FOR THE YEAR ENDED 31 DECEMBER 2017
Regulatory Filings
2018-05-11 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2018
Regulatory Filings
2018-05-03 English
Next Day Disclosure Return
Share Issue/Capital Change
2018-04-30 English
FORM OF PROXY FOR USE AT ANNUAL GENERAL MEETING
AGM Information
2018-04-27 English
NOTICE OF ANNUAL GENERAL MEETING
AGM Information
2018-04-27 English
PROPOSED GRANTING OF GENERAL MANDATES TO ISSUE SHARES AND TO REPURCHASE SHARES, PROPOSED RE-ELECTION OF RETIRING DIRECTORS, DECLARATION OF FINAL DIVIDEND AND NOTICE OF ANNUAL GENERAL MEETING
AGM Information
2018-04-27 English
Annual Report 2017
Annual Report FY 2017
2018-04-27 English
DISCLOSEABLE TRANSACTION IN RELATION TO DEVELOPMENT AND LICENSE AGREEMENT
Capital/Financing Update
2018-04-19 English
Next Day Disclosure Return
Transaction in Own Shares
2018-04-18 English
VOLUNTARY ANNOUNCEMENT NOTICE ON EXPECTED CENTRAL SUBSIDIES OF THE PROJECT ON A NEW INDICATION MDS OF NATIONAL CLASS 1 NEW DRUG XI DI KE
Capital/Financing Update
2018-04-11 English
CHANGE OF AUTHORISED REPRESENTATIVE AND PROCESS AGENT
Board/Management Information
2018-04-10 English
CHANGE OF AUTHORISED REPRESENTATIVE AND PROCESS AGENT
Board/Management Information
2018-04-09 English
VOLUNTARY ANNOUNCEMENT SUCCESSFUL ADMISSION OF XI DI KE INTO JIANGSU PROVINCE'S MEDICINE CATALOGUE FOR MEDICAL INSURANCE
Regulatory Filings
2018-04-09 English
CLARIFICATION ANNOUNCEMENT
Regulatory Filings
2018-04-06 English
CHANGE OF CHIEF FINANCIAL OFFICER AND COMPANY SECRETARY
Board/Management Information
2018-04-06 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2018
Regulatory Filings
2018-04-04 English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2017
Annual Report FY 2017
2018-03-27 English
NOTICE OF BOARD MEETING
Regulatory Filings
2018-03-01 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2018
Capital/Financing Update
2018-03-01 English
Monthly Return of Equity Issuer on Movements in Securities For the month ended 31 January 2018
Regulatory Filings
2018-02-01 English
Monthly Return of Equity Issuer on Movements in Securities For the month ended 31 December 2017
Regulatory Filings
2018-01-02 English